Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity.

Autor: Chan CY; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China., Yuen VW; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China., Chiu DK; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China., Goh CC; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China., Thu KL; The Campbell Family Institute for Breast Cancer Research , Princess Margaret Cancer Centre , Toronto , Ontario , Canada., Cescon DW; The Campbell Family Institute for Breast Cancer Research , Princess Margaret Cancer Centre , Toronto , Ontario , Canada., Soria-Bretones I; The Campbell Family Institute for Breast Cancer Research , Princess Margaret Cancer Centre , Toronto , Ontario , Canada., Law CT; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China., Cheu JW; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China., Lee D; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China., Tse AP; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China., Tan KV; Department of Diagnostic Radiology , The University of Hong Kong , Hong Kong SAR , China., Zhang MS; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China., Wong BP; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China., Wong CM; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; State Key Laboratory of Liver Research , The University of Hong Kong , Hong Kong SAR , China., Khong PL; Department of Diagnostic Radiology , The University of Hong Kong , Hong Kong SAR , China., Ng IO; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; State Key Laboratory of Liver Research , The University of Hong Kong , Hong Kong SAR , China., Bray MR; The Campbell Family Institute for Breast Cancer Research , Princess Margaret Cancer Centre , Toronto , Ontario , Canada., Mak TW; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China.; The Campbell Family Institute for Breast Cancer Research , Princess Margaret Cancer Centre , Toronto , Ontario , Canada., Yau TC; State Key Laboratory of Liver Research , The University of Hong Kong , Hong Kong SAR , China.; Department of Medicine , The University of Hong Kong , Hong Kong SAR , China., Wong CC; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China.; State Key Laboratory of Liver Research , The University of Hong Kong , Hong Kong SAR , China.; Guangdong-Hong Kong Joint Laboratory for RNA Medicine , Sun Yat-Sen University , Guangzhou , China.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2023 Mar 01; Vol. 77 (3), pp. 729-744. Date of Electronic Publication: 2023 Feb 17.

Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.

Autor: Wiedermann U; Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. ursula.wiedermann@meduniwien.ac.at., Garner-Spitzer E; Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Chao Y; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan., Maglakelidze M; ARENSIA Exploratory Medicine LLC, Tbilisi, Georgia., Bulat I; ARENSIA Exploratory Medicine Research Unit, Institute of Oncology, Chisinau, Republic of Moldova., Dechaphunkul A; Department of Medicine, Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Thailand., Arpornwirat W; NCI, Bangkok, Thailand., Charoentum C; Maharaj Nakorn Chiang Mai Hospital, Mueang Chiang Mai District, Thailand., Yen CJ; National Cheng Kung University, Tainan, Taiwan., Yau TC; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong., Tanasanvimon S; King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Maneechavakajorn J; Rajavithi Hospital, Bangkok, Thailand., Sookprasert A; Srinagarind Hospital, Khon Kaen, Thailand., Bai LY; China Medical University Hospital, Taichung City, Taiwan., Chou WC; Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Ungtrakul T; Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Bangkok, Thailand., Drinic M; Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Tobias J; Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Zielinski CC; Central European Cooperative Oncology Group, Vienna, Austria., Chong L; Imugene Limited, Sydney, Australia., Ede NJ; Imugene Limited, Sydney, Australia., Marino MT; Imugene Limited, Sydney, Australia., Good AJ; Imugene Limited, Sydney, Australia.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jul 01; Vol. 27 (13), pp. 3649-3660. Date of Electronic Publication: 2021 Apr 20.

Survival analysis of breast cancer liver metastasis treated by hepatectomy: A propensity score analysis for Chinese women in Hong Kong.

Autor: Cheung TT; Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China. Electronic address: cheung68@hku.hk., Chok KS; Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China., Chan AC; Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China., Tsang SH; Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China., Dai WC; Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China., Yau TC; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China., Kwong A; Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China., Lo CM; Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.

Publikováno v: Hepatobiliary & pancreatic diseases international : HBPD INT [Hepatobiliary Pancreat Dis Int] 2019 Oct; Vol. 18 (5), pp. 452-457. Date of Electronic Publication: 2019 Aug 22.

Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.

Autor: Ng L; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Wan TM; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Man JH; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Chow AK; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Iyer D; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Chen G; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Yau TC; Centre for Cancer Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Lo OS; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Foo DC; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Poon JT; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Leung WK; Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Pang RW; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Centre for Cancer Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Law WL; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Publikováno v: Oncotarget [Oncotarget] 2017 Apr 18; Vol. 8 (16), pp. 27393-27400.